Details of the Drug
General Information of Drug (ID: DM2MJ9F)
Drug Name |
6-bromo-N-m-tolylquinazolin-4-amine
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL1081537; 6-bromo-N-m-tolylquinazolin-4-amine; AC1LEZQQ; Oprea1_147022; Neuro1_000540; MLS000684595; SCHEMBL4349199; MolPort-000-660-263; HMS3380E09; HMS2596L23; ZINC122234; BDBM50311883; AKOS002348862; MCULE-2560701920; SMR000268469; ST50477342; EU-0043981; 6-bromo-N-(3-methylphenyl)quinazolin-4-amine; 6-bromo-N-(3-methylphenyl)-4-quinazolinamine; (6-bromoquinazolin-4-yl)(3-methylphenyl)amine; SR-01000485095
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 314.18 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 4.5 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References